Youssefnia Artmis, Pierre Alicia, Hoder Jeffrey M, MacDonald Michelle, Shaffer Monica J B, Friedman Jessica, Mehler Philip S, Bontempo Amanda, da Silva Francisco C N, Chan Edward D
Department of Physical Therapy at Rusk Rehabilitation, New York University Langone Health, New York, NY, USA.
Doctor of Physical Therapy Program, Duke University, Durham, NC, USA.
J Thorac Dis. 2022 Sep;14(9):3575-3597. doi: 10.21037/jtd-22-410.
Non-tuberculous mycobacterial lung disease (NTM-LD) manifests with bronchiectasis, inflammatory bronchiolitis, nodules, and/or cavitation. Bronchiectasis is characterized by permanently dilated airways wherein mucus accumulates, creating a vicious cycle of chronic injurious inflammation and recurrent infections. While antibiotics are an important part of the treatment of NTM-LD, airway clearance techniques to mitigate this pathogenic mechanism of bronchiectasis as well as other ancillary measures are also important components of NTM-LD treatment. The objective of this contemporaneous Narrative Review is to emphasize the importance of such ancillary measures.
We searched PubMed for the key words of "airway clearance", "pulmonary rehabilitation", "nutrition", "swallowing dysfunction", "gastroesophageal reflux", "vestibular dysfunction", or "cochlear dysfunction" with that of "non-tuberculous mycobacterial lung disease", "bronchiectasis", or "respiratory disease". The bibliographies of identified articles were further searched for relevant articles not previously identified. Each relevant article was reviewed by one or more of the authors and a narrative review was composed.
Herein, we discuss five ancillary treatment measures that are pertinent to patients with bronchiectasis and NTM-LD: (I) airway clearance; (II) physical and pulmonary rehabilitation; (III) nutrition; (IV) diagnosis and mitigation of swallowing dysfunction and of gastroesophageal reflux disease (GERD); and (V) minimization of vestibular and cochlear dysfunction associated with some anti-NTM drugs.
While antibiotics is often the central focus of treatment of NTM-LD, given its propensity for recurrent and recalcitrant infection, other ancillary measures to break the vicious cycle of injurious inflammation and infection should also be emphasized to optimize treatment success.
非结核分枝杆菌肺病(NTM-LD)表现为支气管扩张、炎症性细支气管炎、结节和/或空洞形成。支气管扩张的特征是气道永久性扩张,黏液在其中积聚,形成慢性损伤性炎症和反复感染的恶性循环。虽然抗生素是NTM-LD治疗的重要组成部分,但减轻支气管扩张这种致病机制的气道清除技术以及其他辅助措施也是NTM-LD治疗的重要组成部分。本同期叙述性综述的目的是强调此类辅助措施的重要性。
我们在PubMed中搜索了关键词“气道清除”“肺康复”“营养”“吞咽功能障碍”“胃食管反流”“前庭功能障碍”或“耳蜗功能障碍”以及“非结核分枝杆菌肺病”“支气管扩张”或“呼吸系统疾病”。对已识别文章的参考文献进一步搜索之前未识别的相关文章。每篇相关文章由一位或多位作者进行审阅,并撰写叙述性综述。
在此,我们讨论与支气管扩张和NTM-LD患者相关的五种辅助治疗措施:(I)气道清除;(II)身体和肺康复;(III)营养;(IV)吞咽功能障碍和胃食管反流病(GERD)的诊断与缓解;(V)尽量减少与某些抗NTM药物相关的前庭和耳蜗功能障碍。
虽然抗生素通常是NTM-LD治疗的核心焦点,但鉴于其反复和难治性感染的倾向,还应强调其他辅助措施以打破损伤性炎症和感染的恶性循环,从而优化治疗效果。